Federation Des Caisses Desjardins Du Quebec Atreca, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $13.8 Trillion
- Q1 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Atreca, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 470 shares of BCEL stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
470Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCEL
# of Institutions
9Shares Held
1.04MCall Options Held
0Put Options Held
0-
Bill & Melinda Gates Foundation Seattle, WA913KShares$00.09% of portfolio
-
Xtx Topco LTD London, X054.1KShares$00.0% of portfolio
-
Acadian Asset Management LLC Boston, MA44.1KShares$00.0% of portfolio
-
Gofen & Glossberg LLC20KShares$00.0% of portfolio
-
Endurance Wealth Management, Inc.10.6KShares$00.0% of portfolio
About Atreca, Inc.
- Ticker BCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,876,000
- Description
- Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...